The Effect of the Antioxidant Drug U-74389G on Uric Acid Levels during Ischemia Reperfusion Injury in Rats-Reference-Cited by-同舟云学术

The Effect of the Antioxidant Drug U-74389G on Uric Acid Levels during Ischemia Reperfusion Injury in Rats

Published:2016-09-01 Issue:3 Volume:17 Page:247-250
ISSN:1820-8665
Container-title:Serbian Journal of Experimental and Clinical Research
language:en
Short-container-title:

Author:

Tsompos Constantinos¹,Panoulis Constantinos²,Toutouzas Konstantinos³,Triantafyllou Aggeliki⁴,Zografos George³,Papalois Apostolos⁵

Affiliation:

1. Department of Obstetrics & Gynecology, Mesologi County Hospital, Etoloakarnania, Greece

2. Department of Obstetrics & Gynecology, Aretaieion Hospital, Athens University, Attiki, Greece

3. Department of Surgery, Ippokrateion General Hospital, Athens University, Attiki, Greece

4. Department of Biologic Chemistry, Athens University, Attiki, Greece

5. Experimental Research Centre ELPEN Pharmaceuticals, S.A. Inc., Co., Attiki, Greece

Abstract

Abstract This experimental study examined the effect of the anti-oxidant drug U-74389G in a rat model using a renal ischaemia-reperfusion (IR) protocol. The effects of the molecule were studied biochemically by assessing mean serum uric acid levels (SUA). In total, 40 rats (mean weight = 231.875 g) were used in the study. SUA levels were measured at 60 min of reperfusion for groups A and C and at 120 min of reperfusion for groups B and D. The drug U-74389G was administered only in groups C and D. U-74389G administration non-significantly increased the SUA levels by 15.43%±9.10% (p=0.096) at the representative endpoint of 1.5 h. The reperfusion time non-significantly decreased the SUA levels by 13.61%±9.18% (p=0.126). However, the interaction of U-74389G administration and reperfusion time non-significantly increased the SUA levels by 4.78%±5.64% (p= 0.387). Whether it interacted with the reperfusion time, U-74389G administration non-significantly increased SUA levels. It seems that U-74389G cannot reverse injury to IR tubular epithelial cells within 2 hours.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Reference13 articles.

1. 1. https://www.caymanchem.com/app/template/Product.vm/catalog/75860.

2. 2. Shi F, Cavitt J, Audus LK. 21-aminosteroid and 2-(aminomethyl) chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radic Biol Med. 1995;19:349-357.

3. 3. Tsompos C, Panoulis C, Tutouzas K, Zografos G, Papalois A.: The Acute Effect Of The Antioxidant Drug “U-74389g” On Platelet Distribution Width During Hypoxia Reoxygenation Injury In Rats. J Neurol Stroke 2015; 3(6): 00111. DOI: 10.15406/jnsk.2015.03.00111

4. 4. Tsompos C, Panoulis C, Tutouzas K, Zografos G, Papalois A. Antioxidant 21-aminosteroid “U-74389G” ameliorates the short-time effect of hypoxia-reoxygenation on the platelet count in rats. Folia Med Cracov. 2015;55:25-34.

5. 5. Flessas I, Bramis I, Menenakos E, et al. Effects of lazaroid U-74389G on intestinal ischemia and reperfusion injury in porcine experimental model. Int J Surg. 2014;28:42-8.